Cryoplasty for the treatment of femoropopliteal arterial disease: Will freezing solve the problem of cold feet?

Journal of Vascular and Interventional Radiology

Volumn 16, Issue 8, 2005, Pages 1051-1054

  Jahnke, Thomas ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; RAPAMYCIN;

ANTICOAGULATION; ARTERY DISEASE; ARTERY INTIMA PROLIFERATION; BALLOON DILATATION; BRACHYTHERAPY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRYOPLASTY; CRYOTHERAPY; DEVICE; DOPPLER ECHOGRAPHY; DRUG ELUTING STENT; FEMOROPOPLITEAL ARTERIAL DISEASE; FREEZING; HEALING; HUMAN; NOTE; OUTCOMES RESEARCH; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; RESTENOSIS; SAFETY; STENT; STRETCHING; SUPERFICIAL FEMORAL ARTERY; TREATMENT FAILURE; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 23844532910     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000170850.33165.C5     Document Type: Note

References (35)

1. Jeans WD, Amstrong S, Cole SEA, et al. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology 1990; 177:559-564.
2. Kearney M, Pieczek A, Haley L, et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 1997; 95:1998-2002.
3. Barth KH, Virmani R, Froelich J, et al. Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. Circulation 1996; 93:2161-2169.
4. Steinkamp HJ, Wissgott C, Rademaker J, et al. Short (1-10 cm) superficial femoral artery occlusions: results of treatment with excimer laser angioplasty. Cardiovasc Intervent Radiol 2002; 25:388-396.
5. Zeller T, Frank U, Burgelin K, et al. Early experience with a rotational thrombectomy device for treatment of acute and subacute infra-aortic arterial occlusions. J Endovasc Ther 2003; 10: 322-331.
6. Zeller T, Rastan A, Schwarzwalder U, et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experience. J Endovasc Ther 2004; 11:676-685.
7. Yilmaz S, Sindel T, Ceken K, Alimoglu E, Luleci E. Subintimal recanalization of long superficial femoral artery occlusions through the retrograde popliteal approach. Cardiovasc Intervent Radiol 2001; 24:154-160.
8. Rabbi JF, Kiran RP, Gersten G, Dudrick SJ, Dardik A. Early results with infrainguinal cutting balloon angioplasty limits distal dissection. Ann Vasc Surg 2004; 18:640-643.
9. Grimm J, Müller-Hülsbeck S, Jahnke T, Hubert C, Brossmann J, Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 2001; 12:935-942.
10. Garasic J, Edelman E, Squire JC, Seifert P, Williams M, Rogers C. Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation 2000; 101:812-818.
11. Rosenfield K, Schainfeld R, Pieczek A, et al. Restenosis of endovascular stents from stent compression. J Am Coll Cardiol 1997; 29:328-338.
12. Sabeti S, Schillinger M, Amighi J, et al. Primary patency of femoropopliteal arless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004; 232:516-521.
13. Jahnke T, Voshage G, Müller-Hülsbeck S, et al. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. J Vasc Interv Radiol 2002; 13:257-266.
14. Lugmayr HF, Holzer H, Kastner M, et al. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology. 2002; 222:37-43.
15. Jahnke T, Andresen R, Müller-Hülsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol 2003; 14:41-51.
16. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of expanded polytetrafluoroethylene stent-graft versus angioplasty in the femoropopliteal artery: single-center experience from a prospective, randomized trial. J Vasc Interv Radiol 2003; 14:303-311.
17. Virmani R, Kolodgie FD, Dake MD, et al. Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries. J Vasc Interv Radiol 1999; 10:445-456.
18. Pokrajac B, Potter R, Wolfram RM, et al. Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother Oncol 2005; 74:3-9.
19. Krueger K, Zaehringer M, Bendel M, et al. De novo femoropopliteal stenoses: endovascular gamma irradiation following angioplasty-angiographic and clinical follow-up in a prospective randomized controlled trial. Radiology 2004; 231:546-554.
20. Liermann DD, Bauernsachs R, Schopohl B, Bottcher HD. Five year follow-up after brachytherapy for restenosis in peripheral arteries. Semin Interv Cardiol 1997; 2:133-137.
21. Liistro F, Stankovic G, Di Mario, C, et al. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation 2002; 105:1883-1886.
22. Moses JW, Leon MB, Popma JJ, et al, for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323.
23. Virmani R, Liistro F, Stankovic G, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation 2002; 106:2649-2651.
24. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005; 16:331-338.
25. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104:1188-1193.
26. Virmani R, Farb A, Guagliumi G, et al. Drug-eluting stents: caution and concerns for long-term outcome. Coron Artery Dis 2004; 15:313-318.
27. Laird J, Jaff MR, Biamino G, et al. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol 2005; 16:1067-1073.
28. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction description of a new technic and a preliminary-report of its application. Circulation 1964; 30:654-670.
29. Gage A, Fazekas G, Riley E. Freezing injury to large blood vessels in dogs. Surgery 1967; 61:748-754.
30. Soloff BL, Nagle WA, Moss Jr. AJ, Henle KJ, Crawford JT. Apoptosis induced by cold shock in vitro is dependent on cell growth phase. Biochem Biophys Res Commun 1987; 145:876-883.
31. Tatsutani KN, Joye JD, Virmani R, Taylor MJ. In vitro evaluation of vascular endothelial and smooth muscle cell survival and apoptosis in response to hypothermia and freezing. Cryo Lett 2005; 26:55-64.
32. Fava M, Loyola S, Polydorou A, et al. Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience. J Vasc Interv Radiol 2004; 15:1239-1243.
33. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996; 334:1084-1089.
34. Thompson MM, Budd JS, Eady SL, et al. Platelet deposition after angiplasty is abolished by restoration of the endothelial cell monolayer. J Vasc Surg 1994; 19:478-486.
35. Wilentz JR, Sanborn TA, Haudenschild CC, et al. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation 1987; 75:636-642.